CP-060 (0.5, 5 μM) inhibits rabbit LDL oxidation induced by soybean lipoxygenase by 12.9% and 3.0%, respectively.
CP-060 (100 mg/kg, i.v.) increases the coronary blood flow by 96% in anesthetized dogs.